Views & Analysis Adapting for the future of oncology trials Advanced analytical solutions provider Cytel is at the forefront of rapid changes in oncology R&D.
Deep Dive Moving from autologous to allogeneic ACT paradigms We have come so far in a relatively short time with Adoptive Cellular Transfer (ACT).
Deep Dive Did cancer clinical trials stay on track at ASCO 2019? Chicago is recovering after 40,000 oncologists and cancer experts descended on the city for this year’s ASCO conference.
Deep Dive Why pharma needs honest patient dialogue Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience.
Oncology Deep Dive: Oncology and ASCO 2019 Oncology is currently a more cutting-edge, dynamic field than it has ever been – as demonstrated at this year’s American Society of Clinical Oncology (ASCO) conference.
News Recordati gets €10.9bn takeover bid from private equity firm Recordati has received a takeover offer from private equity group CVC that, if completed, would delist it from the Italian stock exchange.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
